Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 May 2024 | Story Valentino Ndaba | Photo Supplied
UFS Celebrating Africa Month
The University of the Free State celebrates 2024 Africa Month.

May is widely recognised across African nations as Africa Month, a time dedicated to commemorating the establishment of the Organisation of African Unity (OAU) in 1963, a precursor to the African Union (AU). This historic milestone marked a significant shift towards continental unity and the collective pursuit of nation-building, championing the ideals of freedom and liberation from oppression.

On 25 May 2024, Africa celebrates the 61st anniversary of the founding of the OAU, now evolved into the AU. In alignment with this rich tradition, the University of the Free State (UFS) is proud to embrace Africa Day and its core principles once again in 2024, hosting a series of engaging events to highlight the importance of African indigenous knowledge in higher education, both locally and globally.

Honouring our legacy

Even preceding the formation of the OAU in 1963, countless initiatives spearheaded by Africans, both on the continent and within its diaspora, aimed to reclaim Africa’s rightful place on the global stage. South Africans have notably been at the forefront of these efforts, with figures like Pixley ka Isaka Seme delivering his seminal speech on the “Regeneration of Africa” in 1906, a sentiment echoed by subsequent generations through various initiatives geared towards decolonisation and revitalisation.

Africa Month serves as a platform to promote and cultivate appreciation for African arts and culture, fostering robust trade markets and stimulating economic growth across the continent.

Shaping the future

Vision 130 stands as the UFS’s strategic roadmap towards 2034, when the university will celebrate its 130th anniversary. One of its core values of ‘Innovation and Impact’, underscores the institution’s commitment to driving societal progress through impactful endeavours. Embracing creativity and challenging conventional norms, the UFS aims to leverage its knowledge resources to propel the development of the Free State, South Africa, and the African continent, while also contributing to global knowledge and understanding. With a firm commitment to regional engagement, the UFS seeks to be a catalyst for positive change, both locally and continentally.

Events calendar

For 2024, the theme of Africa Month is “Educate and Skill Africa for the 21st Century”, as designated by the African Union. In celebration of this significant milestone, the UFS is organising a diverse array of events throughout the month of May:

5km Fun Run & Walk

The Faculty of Health Sciences will host a 5km Fun Run & Walk, featuring live music, fitness sessions by KovsieFit, and exciting prizes.

Date: 11 May 2024

Time: 06:00

Venue: Francois Retief Building, Bloemfontein Campus.

 

World citizenship and African higher Education

The Office for International Affairs will host an event on World Citizenship and African Higher Education focusing on preparing students for a globally connected world.

Date: 22 May 2024

Time: 16:00-18:00

Venue: Centenary Complex, Bloemfontein Campus

Livestream to Qwaqwa Campus: https://events.ufs.ac.za/e/events.ufs.ac.za/e/africa2024

 

Africa Month book launch

The Centre for Gender and Africa Studies (CGAS) will host a launch a book titled Migration, Borders, and Borderlands꞉ Making National Identity in Southern African Communities which was edited by Dr Munyaradzi Mushonga, Prof John Aerni‑Flessner, Prof Chitja Twala and Dr Grey Magaiza.

Date: 22 May 2024

Time: 14:00 – 15:30

Venue: E0014, Education building, Qwaqwa Campus

Livestream: https://livestream.ufs.ac.za/

 

Africa Day Memorial Lecture

The CGAS on the Qwaqwa Campus will also host the Africa Day Memorial Lecture titled “Peacebuilding in Africa: Challenges, Trends, and Futures” presented by Prof Ismail Rashid.

Date: 22 May 2024

Time: 16:00-18:00

Venue: E0014 Education Building, Qwaqwa Campus

Livestream: https://livestream.ufs.ac.za/

 

Faculty of Theology and Religion Africa Day celebration

The Faculty of Theology and Religion on the Bloemfontein Campus will host an Africa Day Celebration.

Date: 24 May 2024

Time: 12:00-13:00

Venue: 10 H van der Merwe Scholtz Hall, Bloemfontein Campus

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept